Iya Khalil and Colin Hill will lead discussions this coming week at the 12th annual BioPharma & Healthcare Summit hosted by the USA-India Chamber of Commerce (USAIC). The day-long strategic summit gathers senior-level industry executives, academicians, investors and policy makers to discuss topics including:

  • Drug discovery and development
  • Neuro Diseases
  • Oncology
  • Technology Platforms: AI and Blockchain
  • Clinical Trials
  • Value & Access and many more.

The event will take place on May 8 at the Marriott Cambridge and will be Chaired and Emceed for the third time by Dr. Andrew Plump, CMO, CSO & Director of Takeda Pharmaceuticals.

For more information on the summit and to register, visit the USAIC website.